Kidney Cancer

Votrient Pazopanib 400mg Tablets

Votrient (Pazopanib 400 mg Tablets) is a targeted therapy used in the treatment of advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy. Pazopanib is a tyrosine kinase inhibitor that works by blocking certain proteins involved in cancer cell growth and angiogenesis, thereby slowing the spread of cancer. Votrient offers a potent option for managing advanced cancers, improving progression-free survival rates. Our super specialty pharmacy provides high-quality Votrient with personalized treatment plans and expert support to ensure optimal care for cancer patients. Trust us for comprehensive and effective cancer care tailored to your specific needs.

₱25,000 ₱17,000

Pazinib Pazopanib 200mg Tablets

Pazinib (Pazopanib 200 mg Tablets) is a prescription medication used for the treatment of certain types of cancer. Pazopanib is a tyrosine kinase inhibitor that works by blocking the growth of new blood vessels that tumors need to grow, thereby inhibiting the progression of cancer.

Indications:

Pazinib is indicated for the treatment of:

• Advanced renal cell carcinoma (RCC)
• Advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy

How to Use:

• Take Pazinib exactly as prescribed by your healthcare provider.
• Swallow the tablet whole with a full glass of water.
• Do not crush, chew, or break the tablet.
• It should be taken on an empty stomach, at least 1 hour before or 2 hours after eating.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Pazinib may include:

• Diarrhea
• Hypertension (high blood pressure)
• Hair color changes
• Nausea
• Fatigue
• Anorexia
• Vomiting
• Liver function test abnormalities

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring of blood pressure and liver function tests may be required during treatment.
• Use effective contraception to avoid pregnancy while taking Pazinib, as it may harm an unborn baby.
• Pazinib is not recommended for use in breastfeeding women.

Storage:

• Store Pazinib tablets at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the tablets in their original container, tightly closed.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱3,486 ₱3,000

Sutekast Sunitinib 12.5mg Capsules

Sutekast Sunitinib 12.5mg capsules are a targeted therapy medication designed to combat various types of cancers. Each capsule contains 12.5mg of sunitinib, a potent inhibitor of multiple receptor tyrosine kinases involved in cancer progression and angiogenesis.

Usage: These capsules are primarily prescribed for the treatment of:

• Advanced renal cell carcinoma (kidney cancer)
• Progressive pancreatic neuroendocrine tumors (pNET)
• Unresectable or metastatic gastrointestinal stromal tumors (GIST)

Mechanism of Action: Sunitinib works by blocking signals within cancer cells that promote their growth. It targets specific proteins and receptors on cancer cells and blood vessels that support tumor growth, thereby inhibiting their ability to proliferate and metastasize.

Dosage and Administration: Typically, patients are instructed to take Sutekast Sunitinib capsules orally once daily, preferably at the same time each day. Dosage adjustments may be made by healthcare providers based on individual patient response and tolerance to the medication.

Important Considerations:

• It is crucial to follow the prescribed dosage and administration schedule strictly.
• Some common side effects may include fatigue, diarrhea, nausea, and skin discoloration.
• Patients should inform their healthcare provider about any other medications they are taking, including over-the-counter drugs and supplements, to avoid potential interactions.

Storage: Store Sutekast Sunitinib capsules at room temperature away from light and moisture. Keep out of reach of children and pets.

₱0

Sutekast Sunitinib 50mg Capsules

Sutekast (Sunitinib 50 mg Capsules) is a powerful oral multi-kinase inhibitor used in the treatment of various cancers, including advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). Sunitinib works by inhibiting multiple receptor tyrosine kinases involved in tumor growth, angiogenesis, and metastatic progression. It is particularly effective for patients with advanced or metastatic cancer, offering a targeted approach to cancer treatment. Our super specialty pharmacy provides high-quality Sutekast with personalized treatment plans and expert support to ensure the best possible outcomes for cancer patients. Trust us for comprehensive and effective cancer care tailored to your needs.

₱0

Sutekast Sunitinib 25mg Capsules

Sutekast (Sunitinib 25 mg Capsules) is an oral multi-kinase inhibitor used in the treatment of various cancers, including renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). Sunitinib works by inhibiting multiple receptor tyrosine kinases involved in tumor growth, angiogenesis, and metastatic progression. It is particularly effective for patients with advanced or metastatic cancer, providing a targeted approach to cancer treatment. Our super specialty pharmacy offers high-quality Sutekast with personalized treatment plans and expert support to ensure the best possible outcomes for cancer patients. Trust us for comprehensive and effective cancer care tailored to your needs.

₱0

Caboxen Cabozantinib 80 mg Capsules

Caboxen (Cabozantinib 80 mg Capsules) is a highly effective treatment for advanced renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). As a tyrosine kinase inhibitor, Cabozantinib targets multiple pathways involved in tumor growth and angiogenesis, helping to slow the progression of cancer and shrink tumors. Our super specialty pharmacy provides Caboxen with personalized treatment plans and expert support to ensure the best possible outcomes for patients. Trust us for high-quality cancer care and comprehensive support throughout your treatment journey.

₱0

Tucaxen Tucatinib 150 mg Tablet

TABLE OF CONTENT
Mode of Action
Indications
Dosage and Administration
Precautions
Side Effects

Tucaxen Tucatinib 150 mg Tablet is a cutting-edge medication meticulously engineered to target specific proteins involved in the growth and spread of cancer cells. Each tablet contains 150 mg of tucatinib, a potent tyrosine kinase inhibitor renowned for its efficacy in treating certain types of advanced or metastatic cancers.

Mode of Action: Tucatinib, the active ingredient in Tucaxen Tucatinib 150 mg Tablet, selectively inhibits the activity of human epidermal growth factor receptor 2 (HER2) and tyrosine kinase, key drivers of cancer cell proliferation and survival. By disrupting these signaling pathways, tucatinib helps suppress tumor growth and metastasis.

Indications: Tucaxen Tucatinib 150 mg Tablet is indicated for the treatment of:

• HER2-Positive Metastatic Breast Cancer
• HER2-Positive Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

Dosage and Administration: The recommended dosage of Tucaxen Tucatinib 150 mg Tablet is one tablet (150 mg) to be taken orally twice daily with or without food. The dosage may vary based on individual patient factors and concurrent treatments. Patients should adhere strictly to the prescribed regimen provided by a healthcare professional.

Precautions:

• Prior to initiating treatment with Tucaxen Tucatinib 150 mg Tablet, patients should undergo thorough medical evaluation, including assessment of cardiac function and liver enzymes.
• Close monitoring of cardiac function, liver function, and gastrointestinal symptoms is essential during therapy.
• Tucatinib may interact with certain medications, so patients should inform their healthcare provider about all concurrent medications, including over-the-counter drugs and herbal supplements.

Side Effects: Common side effects associated with Tucaxen Tucatinib 150 mg Tablet may include:

• Diarrhea
• Nausea
• Fatigue
• Vomiting
• Elevated liver enzymes
• Decreased appetite
• Hand-foot syndrome (palmar-plantar erythrodysesthesia)

₱120,000 ₱108,000

MabAll Rituximab 500mg Vail

MabAll Rituximab 500mg Vial is a powerful medication designed to target specific cells in the body involved in the immune response. Each vial contains 500mg of rituximab, a monoclonal antibody that selectively targets CD20-positive B-cells, which are often implicated in certain types of cancers and autoimmune diseases.

Mode of Action: Rituximab, the active ingredient in MabAll Rituximab 500mg Vial, works by binding to CD20 antigen present on the surface of B-cells. This binding triggers various immune mechanisms, including antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity, leading to the destruction of targeted B-cells. By depleting these abnormal B-cells, rituximab helps modulate the immune response and combat diseases.

Indications: MabAll Rituximab 500mg Vial is indicated for the treatment of:

• Non-Hodgkin's Lymphoma
• Chronic Lymphocytic Leukemia
• Rheumatoid Arthritis
• Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
• Microscopic Polyangiitis

Dosage and Administration: The recommended dosage of MabAll Rituximab 500mg Vial varies depending on the specific condition being treated, the patient's weight, and other factors. It is typically administered intravenously by a healthcare professional over a specified period. Dosage and administration should be tailored to the individual patient's needs and medical history.

Precautions:

• Prior to initiating treatment with MabAll Rituximab 500mg Vial, patients should undergo thorough medical evaluation, including screening for hepatitis B virus (HBV) infection.
• Close monitoring for signs of infusion reactions, infections, and other adverse effects is essential during and after rituximab therapy.
• Patients should receive appropriate premedication to reduce the risk of infusion-related reactions.
• Rituximab should be used with caution in patients with a history of cardiac or pulmonary conditions.

Side Effects: Common side effects associated with MabAll Rituximab 500mg Vial may include:

• Infusion reactions (fever, chills, nausea, headache, rash)
• Fatigue
• Infections (upper respiratory tract infections, urinary tract infections)
• Low white blood cell count (neutropenia)
• Low platelet count (thrombocytopenia)
• Hypertension (high blood pressure)

₱18,000 ₱15,000

Pazinib Pazopanib 400mg Tablets

Pazinib Pazopanib 400mg Tablet is a medication crafted to combat advanced cancers with precision. Each tablet encapsulates 400mg of pazopanib, a potent kinase inhibitor renowned for its effectiveness in treating various types of cancers.

₱15,000 ₱10,000

Cazanat Cabozantinib 60mg Tablet

Cazanat Cabozantinib 60mg Tablet is a potent medication specifically formulated to combat certain types of advanced cancer. Each tablet contains 60mg of cabozantinib, a targeted therapy known for its efficacy in treating renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.

₱40,000 ₱37,000